SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy

BACKGROUND: Reinfection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been documented, raising public health concerns. SARS-CoV-2 reinfections were assessed in a cohort of antibody-positive persons in Qatar. METHODS: All SARS-CoV-2 antibody-positive persons from April 16...

Descripción completa

Detalles Bibliográficos
Autores principales: Abu-Raddad, Laith J., Chemaitelly, Hiam, Coyle, Peter, Malek, Joel A., Ahmed, Ayeda A., Mohamoud, Yasmin A., Younuskunju, Shameem, Ayoub, Houssein H., Al Kanaani, Zaina, Al Kuwari, Einas, Butt, Adeel A., Jeremijenko, Andrew, Kaleeckal, Anvar Hassan, Latif, Ali Nizar, Shaik, Riyazuddin Mohammad, Abdul Rahim, Hanan F., Nasrallah, Gheyath K., Yassine, Hadi M., Al Kuwari, Mohamed Ghaith, Al Romaihi, Hamad Eid, Al-Thani, Mohamed H., Al Khal, Abdullatif, Bertollini, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079668/
https://www.ncbi.nlm.nih.gov/pubmed/33937733
http://dx.doi.org/10.1016/j.eclinm.2021.100861

Ejemplares similares

Ejemplares similares